Study: R&D Just 22 Percent of Spending by Largest Drug Makers

The largest U.S. pharmaceutical and biotech companies spend just 22 cents out of every dollar on research and development, according to an analysis released recently by the Campaign for Sustainable Rx Pricing. The study, conducted in partnership with GlobalData, combined publicly available financial disclosures with market research on sales and marketing spending for the 10 largest U.S.-based pharmaceutical and biotech companies for which prescription drug sales represented at least half of revenue.